Diphtheria, Tetanus and Pertussis (acellurar component) Booster (dtap) Vaccine 2025 - 2027 (2027 - 2028 and 2028 - 2029)

The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request your tender for Diphtheria, Tetanus and Pertussis (acellurar component) Booster (dtap) Vaccine belonging to the National Vaccination Programme in Finland. The contract period is two years 2025 - …

CPV: 33651600 Vacunas, 33600000 Productos farmacéuticos, 33650000 Antiinfecciosos generales para uso sistémico, vacunas, antineoplásicos e inmunomoduladores
Lugar de ejecución:
Diphtheria, Tetanus and Pertussis (acellurar component) Booster (dtap) Vaccine 2025 - 2027 (2027 - 2028 and 2028 - 2029)
Organismo adjudicador:
Ministry of Social Affairs and Health
Número de premio:
THL/1176/2.02.06/2024

1. Buyer

1.1 Buyer

Official name : Ministry of Social Affairs and Health
Legal type of the buyer : Central government authority
Activity of the contracting authority : Health

2. Procedure

2.1 Procedure

Title : Diphtheria, Tetanus and Pertussis (acellurar component) Booster (dtap) Vaccine 2025 - 2027 (2027 - 2028 and 2028 - 2029)
Description : The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request your tender for Diphtheria, Tetanus and Pertussis (acellurar component) Booster (dtap) Vaccine belonging to the National Vaccination Programme in Finland. The contract period is two years 2025 - 2027. The procurement contains two one-year contract period renewals (1 + 1) to extend the contract for the periods 2027 - 2028 and 2028 - 2029. Estimated quantity for the contract period including contract period renewals is 460,000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The most economically advantageous Tender shall be a Tender with lowest price. Please note that all times given in the Call for Tender refer to local time in Finland. Call for Tenders, annexes: Annex 1 Contract Annex 2 JYSE 2014 SUPPLIES (updated version of April 2022) Annex 3 Delivery schedule Annex 4 Subcontractors Annex 5 Description of the Handi Service
Procedure identifier : f4f738d0-a2d3-4ea7-afc8-1eb6a5d1fd9f
Previous notice : 331d0064-81b5-4525-9c07-5364c767dfe9-01
Internal identifier : THL/1176/2.02.06/2024
Type of procedure : Open
The procedure is accelerated : no
Justification for the accelerated procedure :
Main features of the procedure : An open procedure is applied. The procurement will take place in compliance with the Directive 2014/24/EU on public procurement and the Finnish Act on Public Procurement and Concession Contracts (1397/2016). The estimated value of the procurement will exceed the EU threshold value. In case none of the tenders received meets the requirements of the Call for Tender as intended by the Customer, or if conditions change during the procurement process so that the Customer will be unable to make use of the results of the competitive bidding, the Customer may interrupt the procurement procedure. No compensation will be paid to the tenderers for preparing a tender, presenting it or other participations in the procedure. The Call for Tender documents are available in English.

2.1.1 Purpose

Main nature of the contract : Supplies
Main classification ( cpv ): 33651600 Vaccines
Additional classification ( cpv ): 33600000 Pharmaceutical products
Additional classification ( cpv ): 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents

2.1.2 Place of performance

Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland

2.1.4 General information

Additional information : The purpose of STM and the Customer is to procure Diphtheria, Tetanus and Pertussis (acellurar component) Booster (dtap) Vaccine required for the National Vaccination Programme in Finland. The tendered vaccine must be suitable for school-age children, adolescents and adults. The Customer should prefer syringes without fixed needles. This procurement is not divided into lots. According to Communicable Diseases Act (1227/2016) the Finnish Institute for Health and Welfare has an obligation to supervise the implementation of the national immunization programme and other general vaccinations and monitor the implementation and impact of the vaccinations. Implementing and supervising the implementation of the national immunization programme with one suitable vaccine is more practical than dividing the procurement for lots. There are several target groups eligible for the vaccine in the vaccination programme (for more information on vaccination programme see https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/jaykkakouristus-kurkkumata-hinkuyska-polio-ja-hib-yhdistelmarokotteet/nuorten-ja-aikuisten-kurkkumata-jaykkakouristus-ja-hinkuyskarokote-dtap). From the point of view of the scope of the procurement, it would seem artificial and rather vague to divide the procurement into lots by different target groups, since in fact, it is partly impossible for the contracting entity to estimate the size of the different target groups with sufficient accuracy. Annual vaccine consumption for different target groups may vary (based on e.g the annual epidemiological situation and size of age cohort for target groups). Pursuant to Section 2 of the Act on Public Procurement and Concession Contracts (Procurement Act), the contracting entity shall endeavour to arrange their procurement operations so that procurements can be implemented with optimal economy, quality and orderliness, taking advantage of existing competitive conditions and allowing for environmental and social aspects. If the procurement were divided into lots, the price of the procurement would probably become more expensive, as prices have been higher in previous competitive tendering processes when contracting entity has procured smaller amounts for small risk-groups. This would not make economic sense. In practice, it would also be confusing for the vaccinating staff if different products (vaccine) were used for different target groups. The legal obligation to arrange (and supervise) the implementation of the national immunization programme shall meet its target with one dtap-vaccine. Several different vaccines and contracts would also bring an administrative unwanted burden to contracting entity. From logistical point of view as vaccines need cold chain distribution, it is more environmentally friendly to try to minimize cold chain deliveries for one possible supplier instead of many possible suppliers. More information about National Vaccination Programme and vaccinations can be found on the website of the Finnish Institute for Health and Welfare: https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/jaykkakouristus-kurkkumata-hinkuyska-polio-ja-hib-yhdistelmarokotteet/nuorten-ja-aikuisten-kurkkumata-jaykkakouristus-ja-hinkuyskarokote-dtap The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority". The subject of procurement and the mandatory requirements relating to it are described in detail in this Call for Tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders. If the Supplier during the contract period releases a modified vaccine, the Parties should agree to substitute the Article with the modified vaccine. In case of substitution, all terms and prices in the Contract shall apply without modification. CONTRACT PERIOD The Contract shall enter into a force once the competent signatories of both the Contracting Parties have duly signed the Contract. The Contract shall expire when all contractual duties and obligations have been performed by both Parties. However, the contract period shall be counted from the first day of the month on which the Supplier has handed over the first delivery of the Articles to the Customer´s pharmaceutical wholesaler. The Contract period is two (2) years from the date defined previously above and the estimated quantity to be purchased for this period is 240.000 +/- 20 % doses. After the contract period, the Customer reserves the right for the contract period renewals described in section "Description of renewals". Tenders will be compared in the manner described in section "Grounds for decision" of the Call for Tenders.
Legal basis :
Directive 2014/24/EU

5. Lot

5.1 Lot technical ID : LOT-0000

Title : Diphtheria, Tetanus and Pertussis (acellurar component) Booster (dtap) Vaccine 2025 - 2027 (2027 - 2028 and 2028 - 2029)
Description : The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request your tender for Diphtheria, Tetanus and Pertussis (acellurar component) Booster (dtap) Vaccine belonging to the National Vaccination Programme in Finland. The contract period is two years 2025 - 2027. The procurement contains two one-year contract period renewals (1 + 1) to extend the contract for the periods 2027 - 2028 and 2028 - 2029. Estimated quantity for the contract period including contract period renewals is 460,000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The most economically advantageous Tender shall be a Tender with lowest price. Please note that all times given in the Call for Tender refer to local time in Finland. Call for Tenders, annexes: Annex 1 Contract Annex 2 JYSE 2014 SUPPLIES (updated version of April 2022) Annex 3 Delivery schedule Annex 4 Subcontractors Annex 5 Description of the Handi Service
Internal identifier : THL/1176/2.02.06/2024

5.1.1 Purpose

Main nature of the contract : Supplies
Main classification ( cpv ): 33651600 Vaccines
Additional classification ( cpv ): 33600000 Pharmaceutical products
Additional classification ( cpv ): 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents

5.1.2 Place of performance

Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Additional information :

5.1.6 General information

Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA) : yes
Additional information : The purpose of STM and the Customer is to procure Diphtheria, Tetanus and Pertussis (acellurar component) Booster (dtap) Vaccine required for the National Vaccination Programme in Finland. The tendered vaccine must be suitable for school-age children, adolescents and adults. The Customer should prefer syringes without fixed needles. This procurement is not divided into lots. According to Communicable Diseases Act (1227/2016) the Finnish Institute for Health and Welfare has an obligation to supervise the implementation of the national immunization programme and other general vaccinations and monitor the implementation and impact of the vaccinations. Implementing and supervising the implementation of the national immunization programme with one suitable vaccine is more practical than dividing the procurement for lots. There are several target groups eligible for the vaccine in the vaccination programme (for more information on vaccination programme see https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/jaykkakouristus-kurkkumata-hinkuyska-polio-ja-hib-yhdistelmarokotteet/nuorten-ja-aikuisten-kurkkumata-jaykkakouristus-ja-hinkuyskarokote-dtap). From the point of view of the scope of the procurement, it would seem artificial and rather vague to divide the procurement into lots by different target groups, since in fact, it is partly impossible for the contracting entity to estimate the size of the different target groups with sufficient accuracy. Annual vaccine consumption for different target groups may vary (based on e.g the annual epidemiological situation and size of age cohort for target groups). Pursuant to Section 2 of the Act on Public Procurement and Concession Contracts (Procurement Act), the contracting entity shall endeavour to arrange their procurement operations so that procurements can be implemented with optimal economy, quality and orderliness, taking advantage of existing competitive conditions and allowing for environmental and social aspects. If the procurement were divided into lots, the price of the procurement would probably become more expensive, as prices have been higher in previous competitive tendering processes when contracting entity has procured smaller amounts for small risk-groups. This would not make economic sense. In practice, it would also be confusing for the vaccinating staff if different products (vaccine) were used for different target groups. The legal obligation to arrange (and supervise) the implementation of the national immunization programme shall meet its target with one dtap-vaccine. Several different vaccines and contracts would also bring an administrative unwanted burden to contracting entity. From logistical point of view as vaccines need cold chain distribution, it is more environmentally friendly to try to minimize cold chain deliveries for one possible supplier instead of many possible suppliers. More information about National Vaccination Programme and vaccinations can be found on the website of the Finnish Institute for Health and Welfare: https://thl.fi/aiheet/infektiotaudit-ja-rokotukset/rokotteet-a-o/jaykkakouristus-kurkkumata-hinkuyska-polio-ja-hib-yhdistelmarokotteet/nuorten-ja-aikuisten-kurkkumata-jaykkakouristus-ja-hinkuyskarokote-dtap The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority". The subject of procurement and the mandatory requirements relating to it are described in detail in this Call for Tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders. If the Supplier during the contract period releases a modified vaccine, the Parties should agree to substitute the Article with the modified vaccine. In case of substitution, all terms and prices in the Contract shall apply without modification. CONTRACT PERIOD The Contract shall enter into a force once the competent signatories of both the Contracting Parties have duly signed the Contract. The Contract shall expire when all contractual duties and obligations have been performed by both Parties. However, the contract period shall be counted from the first day of the month on which the Supplier has handed over the first delivery of the Articles to the Customer´s pharmaceutical wholesaler. The Contract period is two (2) years from the date defined previously above and the estimated quantity to be purchased for this period is 240.000 +/- 20 % doses. After the contract period, the Customer reserves the right for the contract period renewals described in section "Description of renewals". Tenders will be compared in the manner described in section "Grounds for decision" of the Call for Tenders.

5.1.10 Award criteria

Criterion :
Type : Price
Name :
Description : Price
Category of award weight criterion : Fixed value (total)
Award criterion number : 100
Description of the method to be used if weighting cannot be expressed by criteria :
Justification for not indicating the weighting of the award criteria :

5.1.15 Techniques

Framework agreement :
No framework agreement
Information about the dynamic purchasing system :
No dynamic purchase system

5.1.16 Further information, mediation and review

Review organisation : Markkinaoikeus -

6. Results

Value of all contracts awarded in this notice : 5 023 200 Euro

6.1 Result lot ldentifier : LOT-0000

At least one winner was chosen.

6.1.2 Information about winners

Winner :
Official name : Sanofi Oy
Tender :
Tender identifier : THL/1176/2.02.06/2024
Identifier of lot or group of lots : LOT-0000
Subcontracting : No
Contract information :
Identifier of the contract : THL/1176/2.02.06/2024
Date on which the winner was chosen : 20/12/2024
Date of the conclusion of the contract : 27/02/2025

6.1.4 Statistical information

Received tenders or requests to participate :
Type of received submissions : Tenders
Number of tenders or requests to participate received : 2
Range of tenders :
Value of the lowest admissible tender : 2 184 000 Euro

8. Organisations

8.1 ORG-0001

Official name : Markkinaoikeus
Registration number : 3006157-6
Postal address : Radanrakentajantie 5
Town : Helsinki
Postcode : 00520
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Telephone : +358 295643300
Roles of this organisation :
Review organisation

8.1 ORG-0002

Official name : Ministry of Social Affairs and Health
Registration number : 0244685-8
Postal address : P.O. BOX 33
Town : Helsinki
Postcode : 00023
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Contact point : Tuija Orre
Telephone : +358 295246000
Roles of this organisation :
Buyer

8.1 ORG-0003

Official name : Sanofi Oy
Registration number : 1048723-8
Town : Espoo
Postcode : 02101
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Telephone : 0201 200 300
Roles of this organisation :
Tenderer
Winner of these lots : LOT-0000

8.1 ORG-0004

Official name : Hansel Oy (Hilma)
Registration number : FI09880841
Postal address : Mannerheiminaukio 1a
Town : Helsinki
Postcode : 00100
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Contact point : eSender
Telephone : 029 55 636 30
Roles of this organisation :
TED eSender

11. Notice information

11.1 Notice information

Notice identifier/version : e23e0fd9-e7f4-4894-abbf-39cd252d6190 - 01
Form type : Result
Notice type : Contract or concession award notice – standard regime
Notice dispatch date : 19/03/2025 13:05 +00:00
Notice dispatch date (eSender) : 19/03/2025 13:07 +00:00
Languages in which this notice is officially available : English

11.2 Publication information

Notice publication number : 00180044-2025
OJ S issue number : 56/2025
Publication date : 20/03/2025